# TEVA PHARMACEUTICAL INDS LTD (TEVA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/TEVA/

- Reporting holders: 2
- Reported value: $364.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [CACTI ASSET MANAGEMENT LLC](https://holderbook.com/funds/1452208-cacti-asset-management-llc/) | $351.3K | 9,000 | 0.0% | 32 |
| [Byrne Asset Management LLC](https://holderbook.com/funds/1911322-byrne-asset-management-llc/) | $13.4K | 340 | 0.0% | 10 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $364.6K |
| Q2 2026 | 681 | $26.9B |
| Q1 2026 | 656 | $21.3B |
| Q4 2025 | 649 | $23.3B |
| Q3 2025 | 565 | $15.9B |
| Q2 2025 | 548 | $13.4B |
| Q1 2025 | 567 | $11.9B |
| Q4 2024 | 594 | $15.8B |
| Q3 2024 | 549 | $12.1B |
| Q2 2024 | 537 | $10.7B |
| Q1 2024 | 490 | $8.9B |
| Q4 2023 | 453 | $6.5B |